Back
HFA Premium Access

Safety and efficacy of first in-human use of muscle-derived stem cells transfected with connexin-43 gene for chronic heart failure

Session: Poster Session 3 - Basic Science: Gene and cell therapy
Topic: Gene and cell therapy
Speaker: Professor E. Straburzynska-Migaj (Poznan, PL)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Ewa Straburzynska-Migaj

Poznan University of Medical Sciences, Poznan (Poland)
1 presentation
0 follower

11 more presentations in this session

HFWM: C-kit+ resident cardiac stem cells improve left ventricular fibrosis in pressure overload

Speaker: Doctor A. Kazakov (Homburg, DE)

Access
Abstract
Slides
Like
Thumbnail

HFWM: An in vivo selection strategy for the identification of novel cytokines inducing cardiac retention of murine mesenchymal stromal cells after myocardial infarction

Speaker: Miss F. Bortolotti (Trieste, IT)

Access
Abstract
Like
Thumbnail

HFWM: The H19 long non-coding RNA regulates pathological cardiac hypertrophy

Access
Like
Thumbnail

Safety and efficacy of transendocardial injection of induced-pluripotent stem cells-derived mesenchymal cells in a swine subacute model of myocardial ischemia.

Speaker: Doctor A. Climent (Valencia, ES)

Access
Abstract
Slides
Like
Thumbnail

A combined cellular and surgical ventricular reconstruction therapeutic approach produces attenuation of remodeling in infarcted rats

Speaker: Doctor C. Kapelios (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Basic Science: Gene and cell therapy

Speakers: Professor E. Straburzynska-Migaj, Doctor A. Kazakov, Miss F. Bortolotti, Doctor A. Climent, Doctor C. Kapelios
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources